特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の糖尿病モニタリング・治療・ドラッグデリバリー市場の概要

US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView

発行 iData Research Inc. 商品コード 392591
出版日 ページ情報 英文 58 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

米国の糖尿病モニタリング・治療・ドラッグデリバリー市場の概要 US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView
出版日: 2016年11月01日 ページ情報: 英文 58 Pages
概要

当レポートでは、米国における糖尿病モニタリング・治療・ドラッグデリバリーの関連市場について分析し、全体的な市場規模の動向見通しや、分野別の詳細動向、主な市場促進・抑制要因、資本取引の動き、企業別の市場シェアなどを調査・推計すると共に、市場の背景事情 (関連疾患・製品の概要、患者数ほか) に関する情報も取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の糖尿病モニタリング・治療・ドラッグデリバリー市場:概要

競争分析

企業の傾向

企業の発展

処置件数

分析対象となる処置コード

分析対象市場

主要分析の更新状況

過去のバージョン

分析手法

  • 分析範囲
  • IDATAの9段階の分析方法

疾患の概要

  • イントロダクション
    • 糖尿病の種類
    • 糖尿病の併発症
    • 1型・2型糖尿病に関連するリスク要因
    • 徴候・症状
    • 糖尿病モニタリング
    • 治療
    • ドラッグデリバリー (薬剤送達) システム

米国の糖尿病モニタリング・治療・ドラッグデリバリー市場の概要

  • 市場概要
  • 市場動向の分析
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業別市場シェアの分析
  • 企業合併・買収 (M&A)

略語一覧

図表一覧

目次
Product Code: iDATA_USDD17_MV

Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period. Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. INTRODUCTION
    • 2.1.1. Types of Diabetes
    • 2.1.2. Diabetes Complications
    • 2.1.3. Risk Factors Associated with Type 1 and Type 2 Diabetes
    • 2.1.4. Signs and Symptoms
    • 2.1.5. Diabetes Monitoring
    • 2.1.6. Treatment
    • 2.1.7. Drug Delivery Systems

U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW

  • 3.1. MARKET OVERVIEW
  • 3.2. TREND ANALYSIS
  • 3.3. DRIVERS AND LIMITERS
    • 3.3.1. Market Drivers
    • 3.3.2. Market Limiters
  • 3.4. COMPETITIVE MARKET SHARE ANALYSIS
  • 3.5. MERGERS AND ACQUISITIONS

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023
  • Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
  • Chart 3-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023
  • Chart 3-2: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S., 2016
  • Chart 3-3: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S.,2023
  • Chart 3-4: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2023
  • Chart 3-5: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(1 of 2)
  • Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(2 of 2)
  • Figure 1-3: Companies Researched in this Report, U.S., 2016
  • Figure 1-4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(1 of 2)
  • Figure 1-5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(2 of 2)
  • Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2016
  • Figure 1-7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
  • Figure 1-8: Procedure Codes Investigated, U.S., 2016
  • Figure 1-9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(1 of 2)
  • Figure 1-10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(2 of 2)
  • Figure 1-11: Key Report Updates
  • Figure 1-12: Version History
  • Figure 2-1: Major Types of Diabetes and Related Pathologies, U.S., 2016
  • Figure 2-2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
  • Figure 2-3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
  • Figure 3-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023(US$M)(1 of 2)
  • Figure 3-2: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023(US$M)(2 of 2)
  • Figure 3-3: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2023(1 of 2)
  • Figure 3-4: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2023(2 of 2)
  • Figure 3-5: Drivers and Limiters, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016
  • Figure 3-6: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016(1 of 2)
  • Figure 3-7: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016(2 of 2)